Skip to main content

Jeff Lagasse

By Jeff Lagasse | 09:45 am | January 23, 2020
Under his leadership, Cleveland Clinic's revenues grew from $3.7 billion in 2004 to $8.5 billion in 2016.
By Jeff Lagasse | 03:21 pm | January 22, 2020
An interventionist approach from the government may not work as intended; market competition and systemic reform will be paramount.
By Jeff Lagasse | 10:55 am | January 22, 2020
The collaboration is meant to spur more engagement in the Go360 program by allowing a broad range of wearables and connected devices.
By Jeff Lagasse | 02:56 pm | January 21, 2020
Trials with non-industry sponsors are far more likely to breach the rules than trials sponsored by industry.
By Jeff Lagasse | 01:31 pm | January 21, 2020
The lack of common terminology, unbundled cost reporting and listing of non-negotiated rates limits the information's value.
By Jeff Lagasse | 11:54 am | January 20, 2020
Spending on cancer drugs was 2% to 5% higher than that of non-participants, and 1% to 7% higher than physician offices -- a modest effect on consumers.
By Jeff Lagasse | 03:19 pm | January 17, 2020
The findings support the notion that the readmission policy is safe and not increasing the risk of death by turning away patients.
By Jeff Lagasse | 10:45 am | January 17, 2020
In all, 19 of 22 models predicted net savings in the first year after implementation, averaging 3.5% of total healthcare spending.
By Jeff Lagasse | 03:05 pm | January 16, 2020
Every year, an estimated 1.3 million U.S. adults with heart disease may qualify for cardiac rehabilitation.
By Jeff Lagasse | 11:14 am | January 16, 2020
The national disparity between gross charges for each procedure is significant with a 297% difference between the lowest and highest gross charge.